Common overdose drug tested as potential stroke treatment
NCT ID NCT04918719
Summary
This study tested whether giving an intravenous antioxidant drug called N-acetylcysteine (NAC) could help people recover better after a stroke. NAC is already FDA-approved for treating acetaminophen overdose. The trial involved 4 adults who had a recent ischemic stroke and were not candidates for standard clot-removal procedures. Participants received either the NAC infusion or a placebo over 20 hours, and their recovery was tracked for 90 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Harbor-UCLA Medical Center
Torrance, California, 90502, United States
Conditions
Explore the condition pages connected to this study.